| Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers G Hripcsak, JD Duke, NH Shah, CG Reich, V Huser, MJ Schuemie, ... Studies in health technology and informatics 216, 574, 2015 | 460 | 2015 |
| Novel data‐mining methodologies for adverse drug event discovery and analysis R Harpaz, W DuMouchel, NH Shah, D Madigan, P Ryan, C Friedman Clinical Pharmacology & Therapeutics 91 (6), 1010-1021, 2012 | 319 | 2012 |
| Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership PE Stang, PB Ryan, JA Racoosin, JM Overhage, AG Hartzema, C Reich, ... Annals of internal medicine 153 (9), 600-606, 2010 | 318 | 2010 |
| Validation of a common data model for active safety surveillance research JM Overhage, PB Ryan, CG Reich, AG Hartzema, PE Stang Journal of the American Medical Informatics Association 19 (1), 54-60, 2012 | 246 | 2012 |
| Performance of pharmacovigilance signal‐detection algorithms for the FDA adverse event reporting system R Harpaz, W DuMouchel, P LePendu, A Bauer‐Mehren, P Ryan, ... Clinical Pharmacology & Therapeutics 93 (6), 539-546, 2013 | 207 | 2013 |
| Characterizing treatment pathways at scale using the OHDSI network G Hripcsak, PB Ryan, JD Duke, NH Shah, RW Park, V Huser, MA Suchard, ... Proceedings of the National Academy of Sciences 113 (27), 7329-7336, 2016 | 182 | 2016 |
| Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership PB Ryan, D Madigan, PE Stang, J Marc Overhage, JA Racoosin, ... Statistics in medicine 31 (30), 4401-4415, 2012 | 166 | 2012 |
| Evaluating the impact of database heterogeneity on observational study results D Madigan, PB Ryan, M Schuemie, PE Stang, JM Overhage, ... American journal of epidemiology 178 (4), 645-651, 2013 | 149 | 2013 |
| A harmonized data quality assessment terminology and framework for the secondary use of electronic health record data MG Kahn, TJ Callahan, J Barnard, AE Bauck, J Brown, BN Davidson, ... Egems 4 (1), 2016 | 130 | 2016 |
| Control of reproductive floral organ identity specification in Arabidopsis by the C function regulator AGAMOUS DS Ó’Maoiléidigh, SE Wuest, L Rae, A Raganelli, PT Ryan, ... The Plant Cell 25 (7), 2482-2503, 2013 | 125 | 2013 |
| Interpreting observational studies: why empirical calibration is needed to correct p‐values MJ Schuemie, PB Ryan, W DuMouchel, MA Suchard, D Madigan Statistics in medicine 33 (2), 209-218, 2014 | 123 | 2014 |
| Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non‐SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 … PB Ryan, JB Buse, MJ Schuemie, F DeFalco, Z Yuan, PE Stang, JA Berlin, ... Diabetes, Obesity and Metabolism 20 (11), 2585-2597, 2018 | 105 | 2018 |
| Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled … JCE Lane, J Weaves, K Kostka, O Alser, A Prats-Uribe, D NEWBY, ... MedRXiv, 2020 | 102 | 2020 |
| Defining a reference set to support methodological research in drug safety PB Ryan, MJ Schuemie, E Welebob, J Duke, S Valentine, AG Hartzema Drug safety 36 (1), 33-47, 2013 | 102 | 2013 |
| Disproportionality methods for pharmacovigilance in longitudinal observational databases I Zorych, D Madigan, P Ryan, A Bate Statistical methods in medical research 22 (1), 39-56, 2013 | 97 | 2013 |
| Feasibility and utility of applications of the common data model to multiple, disparate observational health databases EA Voss, R Makadia, A Matcho, Q Ma, C Knoll, M Schuemie, FJ DeFalco, ... Journal of the American Medical Informatics Association 22 (3), 553-564, 2015 | 93 | 2015 |
| Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases SJ Reisinger, PB Ryan, DJ O'Hara, GE Powell, JL Painter, EN Pattishall, ... Journal of the American Medical Informatics Association 17 (6), 652-662, 2010 | 83 | 2010 |
| Risk of lower extremity amputations in people with type 2 diabetes mellitus treated with sodium‐glucose co‐transporter‐2 inhibitors in the USA: a retrospective cohort study Z Yuan, FJ DeFalco, PB Ryan, MJ Schuemie, PE Stang, JA Berlin, ... Diabetes, Obesity and Metabolism 20 (3), 582-589, 2018 | 79 | 2018 |
| Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis MA Suchard, MJ Schuemie, HM Krumholz, SC You, RJ Chen, N Pratt, ... The Lancet 394 (10211), 1816-1826, 2019 | 77 | 2019 |
| Transparent reporting of data quality in distributed data networks MG Kahn, JS Brown, AT Chun, BN Davidson, D Meeker, PB Ryan, ... Egems 3 (1), 2015 | 75 | 2015 |
Martijn SchuemieJanssen R&DVerified email at ohdsi.org
